Search results for: 'Conversation AI in Healthcare'

Generative AI (GenAI) has garnered huge interest and holds great promise for optimizing business operations by automating routine tasks, streamlining workflows, and providing intelligent insights that improve efficiency, quality, and performance. Ongoing innovation in artificial intelligence (AI) has introduced GenAI with far-reaching implicatio...

In this research deliverable, Frost & Sullivan’s senior analyst team across the healthcare sector provide bold perspectives and predictions for the industry in 2015. The markets covered include pharmaceuticals and biotech, medical devices, medical imaging, and healthcare IT, amongst others. The analysis captures the impact of trends which are expec...

AI has been embedded in telecommunications for over a decade, initially through rule-based automation and early machine learning applied to network optimization, fraud detection, and customer analytics. Even before 5G, CSPs used AI to enable self-optimizing networks (SON), predictive maintenance, and customer experience management—leveraging large ...

Digital Twin technology, or the application of predictive analytics to fields as diverse as manufacturing and space science, is now being considered in the context of healthcare. The attraction is obvious: if one can develop a computer model of a patient, perhaps one can test treatments on the model before applying them to the individual. Rather t...

This edition of the IT, Computing and Communication Technology Opportunity Engine explores growth in AI-driven intelligence, synthetic data, multi-modal AI, intelligent document processing, workflow automation, finance orchestration, compliance automation, embedded finance, cross-border payments, blockchain-enabled trade finance, tokenization, priv...

Asia-Pacific represents the fastest growing region for healthcare information technology (healthcare IT) solutions across the world. Rapidly changing demographic factors coupled with fast-moving government policies and legislations are allowing advanced IT tools to penetrate the market. These tools have the potential to change existing healthcare p...

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, presenting opportunities for innovation. There has been a...

Self-health monitoring products and technologies boost consumer awareness of their health and help them to monitor it, avail timely medical help, and lead a high-quality life. Tools such as wearables, body patches, smartphone applications, lateral flow assays, and other peripheral devices are used to diagnose acute conditions, help patients reach t...

Enterprise AI adoption has accelerated, but visibility into how AI is actually used, governed, and valued inside organizations remains limited. Traditional adoption metrics—such as license counts or surface‑level usage statistics—no longer reflect AI’s real contribution to productivity, risk management, and business performance. As AI shifts decisi...